Buncha Ooraikul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Buncha Ooraikul has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Arunporn Itharat
Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klongluang, Pathumthani 12120, Thailand
6 shared publications - Neal M. Davies
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2H1, Canada
3 shared publications - Sunita Makchuchit
Center of Excellence in Applied Thai Traditional Medicine Research (CEATMR), Thammasat University, Klongluang, Pathumthani 12120, Thailand
3 shared publications - Weerachai Pipatrattanaseree
Regional Medical Science Center 12 Songkhla, Department of Medical Sciences, Ministry of Public Health, Songkhla, 90100, Thailand
3 shared publications - Chonthicha Kongkwamcharoen
Department of Applied Thai Traditional Medicine, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand
2 shared publications - Nuntika Prommee
Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klongluang, Pathumthani, 12120, Thailand
2 shared publications
Latest Publications
- Open Access
A Novel Development of a Curcuma aromatica Salisb Extract-Loaded Hydrogel Patch for Acne and Skin Inflammation: Physicochemical Properties and In Vitro Anti-Inflammatory and Anti-Acne Activities
Background/Objectives: Inflammatory skin disorders such as dermatitis, psoriasis, and acne that affect patients’ quality of life and health require safe and effective active delivery systems. In Thai traditional medicine, Curcuma aromatica has long been used to treat skin disorders and for cosmetic skin care. However, the research is scarce. This study aimed to develop and evaluate a novel anti-inflammatory and anti-acne hydrogel patch containing C. aromatica extract. Methods: The hydrogel patch formulations were prepared, and their mechanical properties, in vitro release, skin permeation, in vitro anti-inflammatory and anti-acne activities, and physicochemical properties were studied. Results: The C. aromatica hydrogel patch (CA2 formulation) made from carrageenan, locust bean gum, PVP-K30, and C. aromatica extract displayed excellent physical appearance and mechanical properties; it was smooth, durable, and flexible. Curcumin, an active ingredient, was released from the C. aromatica hydrogel patch within the first 30 min (19.07 ± 1.14%), reaching its peak at 12 h (50.40 ± 3.94%), with sustained permeation of 38.18 ± 0.45% at 24 h. Data from the drug release and permeation study better fit Higuchi’s kinetic model. Additionally, the CA2 hydrogel patch demonstrated anti-inflammatory activity, with an IC50 value of 19.85 ± 0.82 μg/mL, and was also effective against Cutibacterium acne, with an inhibition zone of 12.70 ± 2.10 mm. Conclusions: The developed C. aromatica hydrogel patch not only showed great physicochemical properties but also had anti-inflammatory and anti-acne activities; it prolonged curcumin release, enabling delivery of the drug to treat skin inflammation disorders. The CA hydrogel patch is suitable for use as an anti-acne facial mask and for inflamed skin areas; however, it should be further evaluated in clinical trials.
Open AccessA Novel Development of a Curcuma aromatica Salisb Extract-Loaded Hydrogel Patch for Acne and Skin Inflammation: Physicochemical Properties and In Vitro Anti-Inflammatory and Anti-Acne Activities
Background/Objectives: Inflammatory skin disorders such as dermatitis, psoriasis, and acne that affect patients’ quality of life and health require safe and effective active delivery systems. In Thai traditional medicine, Curcuma aromatica has long been used to treat skin disorders and for cosmetic skin care. However, the research is scarce. This study aimed to develop and evaluate a novel anti-inflammatory and anti-acne hydrogel patch containing C. aromatica extract. Methods: The hydrogel patch formulations were prepared, and their mechanical properties, in vitro release, skin permeation, in vitro anti-inflammatory and anti-acne activities, and physicochemical properties were studied. Results: The C. aromatica hydrogel patch (CA2 formulation) made from carrageenan, locust bean gum, PVP-K30, and C. aromatica extract displayed excellent physical appearance and mechanical properties; it was smooth, durable, and flexible. Curcumin, an active ingredient, was released from the C. aromatica hydrogel patch within the first 30 min (19.07 ± 1.14%), reaching its peak at 12 h (50.40 ± 3.94%), with sustained permeation of 38.18 ± 0.45% at 24 h. Data from the drug release and permeation study better fit Higuchi’s kinetic model. Additionally, the CA2 hydrogel patch demonstrated anti-inflammatory activity, with an IC50 value of 19.85 ± 0.82 μg/mL, and was also effective against Cutibacterium acne, with an inhibition zone of 12.70 ± 2.10 mm. Conclusions: The developed C. aromatica hydrogel patch not only showed great physicochemical properties but also had anti-inflammatory and anti-acne activities; it prolonged curcumin release, enabling delivery of the drug to treat skin inflammation disorders. The CA hydrogel patch is suitable for use as an anti-acne facial mask and for inflamed skin areas; however, it should be further evaluated in clinical trials.
- Open Access
- 11 August 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-14
Exploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds
Prasachandaeng (PSD) remedy has been empirically used in Thai traditional medicine to treat fever in bile duct and liver and cancer patients through Thai folk doctors. However, there have been no scientific reports on the bioactive compounds and bioactivities related to inflammation-associated carcinogenesis or cytotoxicity against cancer cell lines. In this study, we investigated the chemical content of the remedy, and evaluated its cytotoxic activity against two cancer cell lines in comparison with a non-cancerous cell line and determined tumor necrosis factor-alpha (TNF-α) production in a murine macrophage cell line (RAW 264.7) to evaluate anti-inflammatory activity. A novel HPLC method was used for quality control of its chemical content. Pure compounds from the EtOH extract of D. cochinchinensis were isolated using bioassay-guided fractionation and chemical content of the PSD remedy was determined using HPLC. The cytotoxic activity against the hepatocarcinoma cell line (HepG2) and cholangiocarcinoma cell line (KKU-M156), in comparison with non-cancerous cell line (HaCaT), were investigated using antiproliferative assay (SRB). The anti-inflammatory activity measured by TNF-α production in RAW 264.7 was determined using ELISA. All crude extracts and isolated compounds exhibited significant differences from vincristine sulfate (****p < 0.0001) in their cytotoxic activity against HepG2, KKU-M156, and HaCaT. The PSD remedy exhibited cytotoxic activity against HepG2 and KKU-M156 with IC50 values of 10.45 ± 1.98 (SI = 5.3) and 4.53 ± 0.74 (SI = 12.2) µg/mL, respectively. Some constituents from C. sappan, D. cochinchinensis, M. siamensis, and M. fragrans also exhibited cytotoxic activity against HepG2 and KKU-M156, with IC50 values less than 10 µg/mL. The isolated compounds, i.e., Loureirin B (1), 4-Hydroxy-2,4’-dimethoxydihydrochalcone (2), and Eucomol (3) exhibited moderate cytotoxicity against two cancer cell lines. None of the crude extracts and isolated compounds showed cytotoxicity against HaCaT. D. cochinchinensis and PSD remedy exhibited higher anti-inflammatory activity measured as TNF-α production than acetaminophen. The findings provide evidence of bioactivity for EtOH extracts of PSD remedy and the isolated compounds of D. Cochinchinensis. The results consistent the use clinical activity and use of PSD remedy as a antipyretic treatment for liver and bile duct cancer patients by Thai traditional practitioners.
- 11 August 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-14
Open AccessExploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds
Prasachandaeng (PSD) remedy has been empirically used in Thai traditional medicine to treat fever in bile duct and liver and cancer patients through Thai folk doctors. However, there have been no scientific reports on the bioactive compounds and bioactivities related to inflammation-associated carcinogenesis or cytotoxicity against cancer cell lines. In this study, we investigated the chemical content of the remedy, and evaluated its cytotoxic activity against two cancer cell lines in comparison with a non-cancerous cell line and determined tumor necrosis factor-alpha (TNF-α) production in a murine macrophage cell line (RAW 264.7) to evaluate anti-inflammatory activity. A novel HPLC method was used for quality control of its chemical content. Pure compounds from the EtOH extract of D. cochinchinensis were isolated using bioassay-guided fractionation and chemical content of the PSD remedy was determined using HPLC. The cytotoxic activity against the hepatocarcinoma cell line (HepG2) and cholangiocarcinoma cell line (KKU-M156), in comparison with non-cancerous cell line (HaCaT), were investigated using antiproliferative assay (SRB). The anti-inflammatory activity measured by TNF-α production in RAW 264.7 was determined using ELISA. All crude extracts and isolated compounds exhibited significant differences from vincristine sulfate (****p < 0.0001) in their cytotoxic activity against HepG2, KKU-M156, and HaCaT. The PSD remedy exhibited cytotoxic activity against HepG2 and KKU-M156 with IC50 values of 10.45 ± 1.98 (SI = 5.3) and 4.53 ± 0.74 (SI = 12.2) µg/mL, respectively. Some constituents from C. sappan, D. cochinchinensis, M. siamensis, and M. fragrans also exhibited cytotoxic activity against HepG2 and KKU-M156, with IC50 values less than 10 µg/mL. The isolated compounds, i.e., Loureirin B (1), 4-Hydroxy-2,4’-dimethoxydihydrochalcone (2), and Eucomol (3) exhibited moderate cytotoxicity against two cancer cell lines. None of the crude extracts and isolated compounds showed cytotoxicity against HaCaT. D. cochinchinensis and PSD remedy exhibited higher anti-inflammatory activity measured as TNF-α production than acetaminophen. The findings provide evidence of bioactivity for EtOH extracts of PSD remedy and the isolated compounds of D. Cochinchinensis. The results consistent the use clinical activity and use of PSD remedy as a antipyretic treatment for liver and bile duct cancer patients by Thai traditional practitioners.
- Open Access
- 21 May 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-16
Development of an Assessment Tool of Menstrual-Cycle-Related Signs and Symptoms Based on Thai Traditional Medicine Principles for Evaluation of Women’s Health
Background. Utilization of Thai traditional medicine (TTM) was considered in menstrual-cycle-related signs and symptoms (MCSs) to evaluate womens health. TTM clinicians diagnosed the MCSs by signs, symptoms, and associated factors of patients including a physical examination to find patterns of imbalance elements and the origin of the disorder to optimize treatment. Thus, the purpose of this study was to develop a new assessment tool, the menstrual-cycle-related signs and symptoms questionnaire (MCSQ) based on TTM principles for evaluation of womens menstrual health. Methods. The items and components of the MCSQ were adjusted by TTM expert consensus using the Delphi technique. The content validity of the MCSQ was quantified by the content validity index (CVI). MCSQ were examined by construct validity and internal consistency reliability using exploratory factor analysis (EFA) and Cronbachs α coefficient, respectively. Results: All 19 experts (100) responded to the questionnaires in the three rounds of the Delphi technique. The MCSQ showed high content validity of individual items (I-CVI=0.831.00) and high overall content validity of the questionnaire (S-CVI/AVE=0.98). Overall, 429 of 432 participants completed the questionnaire (99.31). After factor analysis, the final MCSQ was divided into two sections, which consisted of 49 items. The first had 23 items focusing on the MCSs. And, the second had 14 items of personal and medical data including 12 items of associated factors. Cronbachs α coefficient of the final MCSQ was 0.87, and that of each component was between 0.32 and 0.82. Conclusions. This study reports a new MCS questionnaire tool, which was developed from TTM knowledge to evaluate womens health. This questionnaire showed an acceptable level of validity and reliability. Thus, it is also expected to be useful in clinical practice and ongoing research on evaluation of womens health.
- 21 May 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-16
Open AccessDevelopment of an Assessment Tool of Menstrual-Cycle-Related Signs and Symptoms Based on Thai Traditional Medicine Principles for Evaluation of Women’s Health
Background. Utilization of Thai traditional medicine (TTM) was considered in menstrual-cycle-related signs and symptoms (MCSs) to evaluate womens health. TTM clinicians diagnosed the MCSs by signs, symptoms, and associated factors of patients including a physical examination to find patterns of imbalance elements and the origin of the disorder to optimize treatment. Thus, the purpose of this study was to develop a new assessment tool, the menstrual-cycle-related signs and symptoms questionnaire (MCSQ) based on TTM principles for evaluation of womens menstrual health. Methods. The items and components of the MCSQ were adjusted by TTM expert consensus using the Delphi technique. The content validity of the MCSQ was quantified by the content validity index (CVI). MCSQ were examined by construct validity and internal consistency reliability using exploratory factor analysis (EFA) and Cronbachs α coefficient, respectively. Results: All 19 experts (100) responded to the questionnaires in the three rounds of the Delphi technique. The MCSQ showed high content validity of individual items (I-CVI=0.831.00) and high overall content validity of the questionnaire (S-CVI/AVE=0.98). Overall, 429 of 432 participants completed the questionnaire (99.31). After factor analysis, the final MCSQ was divided into two sections, which consisted of 49 items. The first had 23 items focusing on the MCSs. And, the second had 14 items of personal and medical data including 12 items of associated factors. Cronbachs α coefficient of the final MCSQ was 0.87, and that of each component was between 0.32 and 0.82. Conclusions. This study reports a new MCS questionnaire tool, which was developed from TTM knowledge to evaluate womens health. This questionnaire showed an acceptable level of validity and reliability. Thus, it is also expected to be useful in clinical practice and ongoing research on evaluation of womens health.
- Open Access
- 6 March 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-15
Anti-Inflammatory Investigations of Extracts of Zanthoxylum rhetsa
Zanthoxylum rhetsa has been consumed in the diet in northern Thailand and also used as a medicament in ancient scripture for arthropathies. Thus, this study aimed to evaluate the activity of various extracts from differential parts of Z. rhetsa via inhibition of inflammatory mediators (NO, TNF-α, and PGE2) in RAW264.7 macrophages. The chemical composition in active extracts was also analyzed by GC/MS. The parts of this plant studied were whole fruits (F), pericarp (P), and seed (O). The methods of extraction included maceration in hexane, 95 ethanol and 50 ethanol, boiling in water, and water distillation. The results demonstrated that the hexane and 95 ethanolic extract from pericarp (PH and P95) and seed essential oil (SO) were the most active extracts. PH and P95 gave the highest inhibition of NO production with IC50 as 11.99±1.66μg/ml and 15.33±1.05μg/ml, respectively, and they also showed the highest anti-inflammatory effect on TNF-α with IC50 as 36.08±0.55μg/ml and 34.90±2.58μg/ml, respectively. PH and P95 also showed the highest inhibitory effect on PGE2 but less than SO with IC50 as 13.72±0.81μg/ml, 12.26±0.71μg/ml, and 8.61±2.23μg/ml, respectively. 2,3-Pinanediol was the major anti-inflammatory compound analyzed in PH (11.28) and P95 (19.82) while terpinen-4-ol constituted a major anti-inflammatory compound in SO at 35.13. These findings are the first supportive data for ethnomedical use for analgesic and anti-inflammatory activity in acute (SO) and chronic (PH and P95) inflammation.
- 6 March 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-15
Open AccessAnti-Inflammatory Investigations of Extracts of Zanthoxylum rhetsa
Zanthoxylum rhetsa has been consumed in the diet in northern Thailand and also used as a medicament in ancient scripture for arthropathies. Thus, this study aimed to evaluate the activity of various extracts from differential parts of Z. rhetsa via inhibition of inflammatory mediators (NO, TNF-α, and PGE2) in RAW264.7 macrophages. The chemical composition in active extracts was also analyzed by GC/MS. The parts of this plant studied were whole fruits (F), pericarp (P), and seed (O). The methods of extraction included maceration in hexane, 95 ethanol and 50 ethanol, boiling in water, and water distillation. The results demonstrated that the hexane and 95 ethanolic extract from pericarp (PH and P95) and seed essential oil (SO) were the most active extracts. PH and P95 gave the highest inhibition of NO production with IC50 as 11.99±1.66μg/ml and 15.33±1.05μg/ml, respectively, and they also showed the highest anti-inflammatory effect on TNF-α with IC50 as 36.08±0.55μg/ml and 34.90±2.58μg/ml, respectively. PH and P95 also showed the highest inhibitory effect on PGE2 but less than SO with IC50 as 13.72±0.81μg/ml, 12.26±0.71μg/ml, and 8.61±2.23μg/ml, respectively. 2,3-Pinanediol was the major anti-inflammatory compound analyzed in PH (11.28) and P95 (19.82) while terpinen-4-ol constituted a major anti-inflammatory compound in SO at 35.13. These findings are the first supportive data for ethnomedical use for analgesic and anti-inflammatory activity in acute (SO) and chronic (PH and P95) inflammation.
- 1 March 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 268, 113520
Ethnopharmacological analysis from Thai traditional medicine called prasachandaeng remedy as a potential antipyretic drug
- 1 March 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 268, 113520
Ethnopharmacological analysis from Thai traditional medicine called prasachandaeng remedy as a potential antipyretic drug
- Open Access
- 28 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-11
Effects of Various Preextraction Treatments of Crinum asiaticum Leaf on Its Anti-Inflammatory Activity and Chemical Properties
Crinum asiaticum Linn. has been used in Thai traditional medicine to relieve inflammatory symptoms and treat osteoarthritis. There have been reports on its potent anti-inflammatory property but nothing on the effects of different pretreatments on its chemical properties and anti-inflammatory activity. Pretreatment of herbal raw materials is an important step which affects the overall quality of Thai traditional medicine. The objectives of this study were to investigate different treatments of C. asiaticum leaves prior to ethanolic extraction and to compare the extracts for their anti-inflammatory activity and chemical properties. The treatments included hot air drying in an oven, microwave drying, traditional grilling on a charcoal stove before drying in an oven, and temperature shock in hot and cold water before hot air drying. The anti-inflammatory activity and chemical properties of the extracts were analyzed using the established methods. Results showed that 95 ethanolic extract of hot air oven-dried leaves had the highest anti-inflammatory activity and total phenolic and lycorine contents. We recommend hot air drying as a preextraction treatment for C. asiaticum leaves for its simplicity, best retention of the herbal quality, and suitability for scaling up to an industrial process.
- 28 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-11
Open AccessEffects of Various Preextraction Treatments of Crinum asiaticum Leaf on Its Anti-Inflammatory Activity and Chemical Properties
Crinum asiaticum Linn. has been used in Thai traditional medicine to relieve inflammatory symptoms and treat osteoarthritis. There have been reports on its potent anti-inflammatory property but nothing on the effects of different pretreatments on its chemical properties and anti-inflammatory activity. Pretreatment of herbal raw materials is an important step which affects the overall quality of Thai traditional medicine. The objectives of this study were to investigate different treatments of C. asiaticum leaves prior to ethanolic extraction and to compare the extracts for their anti-inflammatory activity and chemical properties. The treatments included hot air drying in an oven, microwave drying, traditional grilling on a charcoal stove before drying in an oven, and temperature shock in hot and cold water before hot air drying. The anti-inflammatory activity and chemical properties of the extracts were analyzed using the established methods. Results showed that 95 ethanolic extract of hot air oven-dried leaves had the highest anti-inflammatory activity and total phenolic and lycorine contents. We recommend hot air drying as a preextraction treatment for C. asiaticum leaves for its simplicity, best retention of the herbal quality, and suitability for scaling up to an industrial process.
- Open Access
- 18 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-10
Efficacy and Safety of Sahastara Remedy Extract Capsule in Primary Knee Osteoarthritis: A Randomized Double-Blinded Active-Controlled Trial
Sahastara (SHT) remedy is a Thai traditional medicine described in the Thai National List of Essential Medicine (NLEM) for the relief of muscle pain. The purpose of this study was to investigate the efficacy and safety of SHT remedy extract capsule for treating primary OA. A phase 2, double-blind, randomized, and controlled trial study was used to determine the clinical efficacy and safety of SHT in comparison with diclofenac for the treatment of knee OA. The outcome of reduce pain was measured from VAS, 100 meter time walk, and the WOMAC score of day 14 and day 28 which should reduce significantly when compared with day 0 and should be equal with or better than diclofenac. Blood pressure and blood chemistry values at day 14 and day 28 did not change when compared with day 0. The results found that SHT remedy ethanolic extract capsule can reduce all OA knee scores at day 14 and day 28 significantly when compared with day 0 and also no significant difference with diclofenac ( ). The SHT also showed safety values on blood pressure and blood chemistry. The SHT was observed that it had no serious side effect. The results of this study are the first report of using the SHT ethanolic extract capsule in the treatment of primary osteoarthritis of the knee. It can be recommended as an anti-inflammatory herbal drug for reducing pain in knee osteoarthritis patients.
- 18 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-10
Open AccessEfficacy and Safety of Sahastara Remedy Extract Capsule in Primary Knee Osteoarthritis: A Randomized Double-Blinded Active-Controlled Trial
Sahastara (SHT) remedy is a Thai traditional medicine described in the Thai National List of Essential Medicine (NLEM) for the relief of muscle pain. The purpose of this study was to investigate the efficacy and safety of SHT remedy extract capsule for treating primary OA. A phase 2, double-blind, randomized, and controlled trial study was used to determine the clinical efficacy and safety of SHT in comparison with diclofenac for the treatment of knee OA. The outcome of reduce pain was measured from VAS, 100 meter time walk, and the WOMAC score of day 14 and day 28 which should reduce significantly when compared with day 0 and should be equal with or better than diclofenac. Blood pressure and blood chemistry values at day 14 and day 28 did not change when compared with day 0. The results found that SHT remedy ethanolic extract capsule can reduce all OA knee scores at day 14 and day 28 significantly when compared with day 0 and also no significant difference with diclofenac ( ). The SHT also showed safety values on blood pressure and blood chemistry. The SHT was observed that it had no serious side effect. The results of this study are the first report of using the SHT ethanolic extract capsule in the treatment of primary osteoarthritis of the knee. It can be recommended as an anti-inflammatory herbal drug for reducing pain in knee osteoarthritis patients.